Literature DB >> 26565540

Vitamin D status in perinatally HIV-infected Thai children receiving antiretroviral therapy.

Linda Aurpibul, Sirintip Sricharoenchai, Orasri Wittawatmongkol, Virat Sirisanthana, Wanatpreeya Phongsamart, Tavitiya Sudjaritruk, Kulkanya Chokephaibulkit.   

Abstract

BACKGROUND: Low vitamin D level is associated with adverse health outcomes and compromises HIV treatment response. We assess vitamin D status in HIV-infected Thai children receiving combination antiretroviral therapy (cART).
METHODS: A cross-sectional study in perinatally HIV-infected children. Vitamin D deficiency and vitamin D insufficiency were defined as serum 25-hydroxyvitamin D (25-OHD) level <20, and 21-29 ng/mL, respectively.
RESULTS: Eighty participants were enrolled. Their median age was 12.2 years. The median CD4 lymphocyte count was 784 cell/mm3; 95% had HIV RNA <50 copies/mL. The median (interquartile range, IQR) 25-OHD level was 33.5 (26.2-39.8) ng/mL. Thirty-four (43%) participants had low vitamin D level; 26 (33%) and 8 (10%) had vitamin D insufficiency and deficiency, respectively. In multivariate analysis, only geographic location was significantly associated with low vitamin D level.
CONCLUSIONS: Most of perinatally HIV-infected children receiving cART had low vitamin D level. Calcium and vitamin D supplement might be beneficial.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26565540     DOI: 10.1515/jpem-2015-0203

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  3 in total

Review 1.  Vitamin D and bone loss in HIV.

Authors:  Corrilynn O Hileman; Edgar T Overton; Grace A McComsey
Journal:  Curr Opin HIV AIDS       Date:  2016-05       Impact factor: 4.283

Review 2.  Continued Interest and Controversy: Vitamin D in HIV.

Authors:  Evelyn Hsieh; Michael T Yin
Journal:  Curr HIV/AIDS Rep       Date:  2018-06       Impact factor: 5.071

Review 3.  Bone health and HIV in resource-limited settings: a scoping review.

Authors:  Flavia Kiweewa Matovu; Lalita Wattanachanya; Mags Beksinska; John M Pettifor; Kiat Ruxrungtham
Journal:  Curr Opin HIV AIDS       Date:  2016-05       Impact factor: 4.283

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.